Geoffrey M. Parker, Director at Better Therapeutics, Inc. (BTTX), bought 1,370,050 shares at $0.73 ($1.0M) on 2023-07-27, disclosed to the SEC on 2023-07-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.73 | 685,025 | $500K | 50.0% |
| 2 | $0.73 | 685,025 | $500K | 50.0% |
| Total | $0.73 avg | 1,370,050 | $1.0M | 100% |
| Filing → |
| ALLO | SELL | 2025-10-23 | $46K | — | Filing → |
| PRGO | BUY | 2025-08-20 | $201K | — | Filing → |
| PRGO | BUY | 2025-05-14 | $95K | — | Filing → |